• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hair depigmentation and vitiligo-like lesions in a leukaemic paediatric patient during chemotherapy with dasatinib.

作者信息

Brazzelli Valeria, Grasso Vincenzo, Barbaccia Vincenzo, Manna Giambattista, Rivetti Nicolò, Zecca Marco, Giorgiani Giovanna, Vassallo Camilla, Borroni Giovanni

出版信息

Acta Derm Venereol. 2012 Mar;92(2):218-9. doi: 10.2340/00015555-1289.

DOI:10.2340/00015555-1289
PMID:22307953
Abstract
摘要

相似文献

1
Hair depigmentation and vitiligo-like lesions in a leukaemic paediatric patient during chemotherapy with dasatinib.一名白血病患儿在接受达沙替尼化疗期间出现毛发色素脱失和白癜风样皮损。
Acta Derm Venereol. 2012 Mar;92(2):218-9. doi: 10.2340/00015555-1289.
2
Dasatinib (Sprycel) for CML and Ph + ALL.达沙替尼（施达赛）用于治疗慢性粒细胞白血病和费城染色体阳性的急性淋巴细胞白血病。
Med Lett Drugs Ther. 2007 Jan 15;49(1252):6-7.
3
Dasatinib-induced leukotrichia in a patient with chronic myelogenous leukemia.达沙替尼致慢性髓性白血病患者白发病
JAMA Dermatol. 2013 May;149(5):637-9. doi: 10.1001/jamadermatol.2013.75.
4
Dasatinib: for some difficult cases of adult leukaemia.达沙替尼：用于治疗某些成人白血病疑难病例。
Prescrire Int. 2008 Aug;17(96):149-50.
5
Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure.达沙替尼在对伊马替尼耐药且伴有肾衰竭的费城染色体阳性急性淋巴细胞白血病患者中的应用。
J Clin Pharm Ther. 2008 Jun;33(3):329-30. doi: 10.1111/j.1365-2710.2008.00916.x.
6
Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia.
Br J Haematol. 2015 Jun;169(5):612. doi: 10.1111/bjh.13407. Epub 2015 Apr 8.
7
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
8
Rapid-onset pulmonary arterial hypertension in a patient with acute lymphoblastic leukemia treated with dasatinib.一名接受达沙替尼治疗的急性淋巴细胞白血病患者出现快速进展的肺动脉高压。
Herz. 2013 Dec;38(8):931-3. doi: 10.1007/s00059-013-3765-7. Epub 2013 Feb 23.
9
Hair depigmentation during chemotherapy with dasatinib, a dual Bcr-Abl/Src family tyrosine kinase inhibitor.
J Drugs Dermatol. 2009 Apr;8(4):395-8.
10
Reversible hair depigmentation in a patient treated with imatinib.
Leuk Res. 2011 Jun;35(6):e64-6. doi: 10.1016/j.leukres.2010.11.028. Epub 2010 Dec 19.

引用本文的文献

1
Targeted therapies induced depigmentation: a review.靶向治疗引起的色素脱失：综述
Front Immunol. 2025 Aug 8;16:1625738. doi: 10.3389/fimmu.2025.1625738. eCollection 2025.
2
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity.介导酪氨酸激酶抑制剂心脏毒性的细胞内信号通路。
Heart Fail Clin. 2022 Jul;18(3):425-442. doi: 10.1016/j.hfc.2022.02.003. Epub 2022 Jun 1.
3
Dasatinib-Induced Hypopigmentation in Pediatric Patient with Chronic Myeloid Leukemia: A Case Report and Review of the Literature.
达沙替尼致慢性粒细胞白血病患儿色素减退：1例报告并文献复习
Case Rep Dermatol Med. 2018 Jul 9;2018:4062431. doi: 10.1155/2018/4062431. eCollection 2018.
4
Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.接受靶向抗癌药物治疗患者的色素沉着变化：一项系统评价和荟萃分析。
J Am Acad Dermatol. 2017 Nov;77(5):902-910.e2. doi: 10.1016/j.jaad.2017.06.044. Epub 2017 Sep 14.
5
Development of Asymmetric Facial Depigmentation in a Patient Treated with Dasatinib with New-Onset Hypovitaminosis D: Case Report and Review of the Literature.达沙替尼治疗患者出现不对称面部色素脱失伴新发维生素D缺乏症：病例报告及文献综述
Case Rep Dermatol Med. 2017;2017:9359086. doi: 10.1155/2017/9359086. Epub 2017 Mar 23.
6
Diffuse hypopigmentation followed by hyperpigmentation in an african american woman with hemangiopericytoma treated with dasatinib.一名患有血管外皮细胞瘤的非裔美国女性在接受达沙替尼治疗后出现弥漫性色素减退，随后出现色素沉着。
J Clin Diagn Res. 2014 Nov;8(11):QD01-2. doi: 10.7860/JCDR/2014/8055.5160. Epub 2014 Nov 20.
7
Inhibition of c-Kit by tyrosine kinase inhibitors.酪氨酸激酶抑制剂对c-Kit的抑制作用。
Haematologica. 2015 Mar;100(3):e77-9. doi: 10.3324/haematol.2014.117028. Epub 2014 Nov 25.
8
Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma.一项针对新诊断的弥漫性内在脑桥神经胶质瘤患儿的凡德他尼和达沙替尼的 I 期临床试验、药代动力学和药效学研究。
Clin Cancer Res. 2013 Jun 1;19(11):3050-8. doi: 10.1158/1078-0432.CCR-13-0306. Epub 2013 Mar 27.